Skip to main content

DNAJC11 Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-87287

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-87287

Key Product Details

Species Reactivity

Human

Applications

Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit

Concentration

0.5 mg/ml

Product Specifications

Immunogen

The immunogen is a synthetic peptide directed towards the C-terminal region of DNAJC11. Peptide sequence: IIKPYLRAQKEKELEKQRESAATDVLQKKQEAESAVRLMQESVRRIIEAE The peptide sequence for this immunogen was taken from within the described region.

Clonality

Polyclonal

Host

Rabbit

Scientific Data Images for DNAJC11 Antibody

Western Blot: DNAJC11 Antibody [NBP2-87287]

Western Blot: DNAJC11 Antibody [NBP2-87287]

Western Blot: DNAJC11 Antibody [NBP2-87287] - WB Suggested Anti-DNAJC11 Antibody. Titration: 1.0 ug/ml. Positive Control: Fetal Heart

Applications for DNAJC11 Antibody

Application
Recommended Usage

Western Blot

1.0 ug/ml

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS, 2% Sucrose

Preservative

0.09% Sodium Azide

Concentration

0.5 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: DNAJC11

Alternate Names

dJ126A5.1, DnaJ (Hsp40) homolog, subfamily C, member 11, dnaJ homolog subfamily C member 11, FLJ10737, novel DnaJ domain-containing protein

Gene Symbol

DNAJC11

Additional DNAJC11 Products

Product Documents for DNAJC11 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for DNAJC11 Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...